|
BE615511A
(enExample)
|
1961-03-25 |
|
|
|
|
NL292958A
(enExample)
|
1962-05-29 |
1900-01-01 |
|
|
|
GB8809205D0
(en)
|
1988-04-19 |
1988-05-25 |
Nye P C G |
Treatment of oedema
|
|
US5137871A
(en)
|
1989-07-28 |
1992-08-11 |
Regents Of The University Of California |
Treatment to reduce edema for brain and musculature injuries
|
|
DE4010536A1
(de)
*
|
1990-04-02 |
1991-10-10 |
Boehringer Mannheim Gmbh |
Pharmazeutische waessrige loesung von 4-(2-(benzolsulfonylamino)-ethyl)-phenoxyessigsaeure
|
|
DE4113820A1
(de)
|
1991-04-27 |
1992-10-29 |
Boehringer Mannheim Gmbh |
Verwendung von torasemid zur behandlung von hirnoedemen
|
|
US5486530A
(en)
|
1991-04-27 |
1996-01-23 |
Boehringer Mannheim Gmbh |
Use of torasemide for the treatment of brain oedemas
|
|
US5741671A
(en)
|
1991-12-12 |
1998-04-21 |
The Johns Hopkins University |
Isolation cloning and expression of transmembrane water channel aquaporin 1(AQP1)
|
|
US5858702A
(en)
|
1991-12-13 |
1999-01-12 |
The Johns Hopkins University |
Isolation, cloning and expression of transmembrane water channel Aquaporin 5 (AQP5)
|
|
US5519035A
(en)
|
1993-07-02 |
1996-05-21 |
Cornell Research Foundation, Inc. |
Treatment of stroke or in anticipation of the occurrence of brain ischemia
|
|
US20060167110A1
(en)
|
1995-01-13 |
2006-07-27 |
Blume Cherly D |
Methods for treating cerebrovascular disease by administering desmethylselegiline
|
|
EP0886471A4
(en)
|
1996-11-18 |
2002-07-17 |
Emisphere Tech Inc |
METHODS AND COMPOSITIONS FOR INDUCING ORAL TOLERANCE IN MUZZLES
|
|
CA2298824A1
(en)
|
1997-08-06 |
1999-02-18 |
Smithkline Beecham Corporation |
Macrophage scavenger receptor antagonists for use in the treatment of cardiovascular diseases
|
|
US5905090A
(en)
|
1998-04-29 |
1999-05-18 |
Italfarmaco S.P.A. |
Analogues of the active metabolite of leflunomide
|
|
CO5180581A1
(es)
*
|
1999-09-30 |
2002-07-30 |
Pfizer Prod Inc |
Compuestos para el tratamiento de la isquemia ciones farmaceuticas que los contienen para el tratamiento de la isquemia
|
|
US6500809B1
(en)
|
1999-11-12 |
2002-12-31 |
Neuron Therapeutics, Inc. |
Hyperoncotic artificial cerebrospinal fluid and method of treating neural tissue edema therewith
|
|
ATE257479T1
(de)
|
1999-12-10 |
2004-01-15 |
Pfizer |
5-ring heteroarylsubstituierte 1,4- dihydropyridine als bradykinin antagonisten
|
|
EP1847263A3
(en)
|
2000-12-18 |
2009-08-26 |
Institute of Medicinal Molecular Design, Inc. |
Inhibitors against the production and release of inflammatory cytokines
|
|
US8980952B2
(en)
|
2002-03-20 |
2015-03-17 |
University Of Maryland, Baltimore |
Methods for treating brain swelling with a compound that blocks a non-selective cation channel
|
|
DK2438913T3
(da)
|
2002-03-20 |
2020-06-22 |
Univ Maryland |
Ikke-selektiv kationkanal i neurale celler og forbindelser, der blokerer kanalen, til anvendelse i behandling af opsvulmning af hjernen
|
|
EA008769B1
(ru)
|
2002-06-05 |
2007-08-31 |
Инститьют Оф Медисинал Молекьюлар Дизайн. Инк. |
Лекарственное средство для лечения диабета
|
|
EA009523B1
(ru)
|
2002-06-05 |
2008-02-28 |
Инститьют Оф Медисинал Молекьюлар Дизайн. Инк. |
Ингибиторы в отношении активации ар-1 и nfat
|
|
EA008622B1
(ru)
|
2002-06-05 |
2007-06-29 |
Инститьют Оф Медисинал Молекьюлар Дизайн. Инк. |
Ингибиторы ассоциированной с иммунитетом протеинкиназы
|
|
TW200406198A
(en)
|
2002-06-06 |
2004-05-01 |
Inst Med Molecular Design Inc |
O-substituted hydroxyaryl derivatives
|
|
CN1658872B
(zh)
|
2002-06-06 |
2010-09-22 |
株式会社医药分子设计研究所 |
抗过敏药
|
|
AU2003242108B2
(en)
|
2002-06-10 |
2008-09-11 |
Institute Of Medicinal Molecular Design, Inc. |
Medicament for treatment of cancer
|
|
US20060089395A1
(en)
|
2002-06-10 |
2006-04-27 |
Susumu Muto |
Nf-kb activation inhibitors
|
|
CA2488979A1
(en)
|
2002-06-11 |
2003-12-18 |
Institute Of Medicinal Molecular Design, Inc. |
Medicament for treatment of neurodegenerative diseases
|
|
KR20050029209A
(ko)
|
2002-07-15 |
2005-03-24 |
미리어드 제네틱스, 인크. |
화합물, 조성물 및 이의 사용방법
|
|
EP1590458B1
(en)
|
2003-02-06 |
2012-10-31 |
Queen's University Of Belfast |
Bradykinin b2 receptor antagonist peptide from amphibian skin
|
|
NZ543201A
(en)
|
2003-05-01 |
2007-05-31 |
Innogene Kalbiotech Pte Ltd |
Lactate containing pharmaceutical composition and uses thereof
|
|
KR20060054308A
(ko)
|
2003-07-16 |
2006-05-22 |
가부시키가이샤 이야쿠 분지 셋케이 겐쿠쇼 |
피부 색소침착의 치료제
|
|
ZA200603515B
(en)
*
|
2003-10-08 |
2007-11-28 |
Vertex Pharma |
Modulators of ATP-binding cassette transporters
|
|
US8467876B2
(en)
|
2003-10-15 |
2013-06-18 |
Rmx, Llc |
Breathing disorder detection and therapy delivery device and method
|
|
US20070254956A1
(en)
|
2003-10-29 |
2007-11-01 |
Koichi Shudo |
Medicament for Therapeutic and/or Preventive Treatment of Restenosis or Reocclusion After Vascular Recanalization Operation
|
|
WO2005056020A2
(en)
|
2003-12-02 |
2005-06-23 |
Corgentech, Inc. |
Nf-kb oligonucleotide decoy molecules
|
|
AU2005287090A1
(en)
|
2004-09-18 |
2006-03-30 |
Department Of Veterans Affairs |
Therapeutic agents targeting the NCca-ATP channel and methods of use thereof
|
|
ATE486606T1
(de)
|
2004-09-18 |
2010-11-15 |
Univ Maryland |
Therapeutische mittel zum targeting des ncca-atp- kanals und verwendungsverfahren dafür
|
|
US7601745B2
(en)
|
2004-09-27 |
2009-10-13 |
4Sc Ag |
Heterocyclic NF-kB inhibitors
|
|
KR20070111475A
(ko)
|
2005-01-04 |
2007-11-21 |
노파르티스 아게 |
만성 변비 환자에서 테가세로드의 효능을 확인하기 위한바이오마커
|
|
MY147790A
(en)
*
|
2005-04-28 |
2013-01-31 |
Takeda Pharmaceutical |
Stable emulsion composition
|
|
WO2007084464A2
(en)
|
2006-01-17 |
2007-07-26 |
The University Of North Carolina At Chapel Hill |
Water channel blockers and methods of use thereof
|
|
JP4273235B2
(ja)
|
2006-06-01 |
2009-06-03 |
国立大学法人 新潟大学 |
アクアポリン４阻害薬
|
|
AR061246A1
(es)
|
2006-06-06 |
2008-08-13 |
Genentech Inc |
Anticuerpos anti- dill4 y metodos que los usan
|
|
WO2007143689A2
(en)
|
2006-06-06 |
2007-12-13 |
Genentech, Inc. |
Compositions and methods for modulating vascular development
|
|
US7671058B2
(en)
|
2006-06-21 |
2010-03-02 |
Institute Of Medicinal Molecular Design, Inc. |
N-(3,4-disubstituted phenyl) salicylamide derivatives
|
|
WO2008046014A1
(en)
|
2006-10-12 |
2008-04-17 |
Remedy Pharmaceuticals, Inc. |
Treatment of alzheimer's disease using compounds that reduce the activity of non-selective ca++- activated atp-sensitive cation channels regulated by sur1 receptors
|
|
US10004703B2
(en)
|
2006-10-12 |
2018-06-26 |
Biogen Chesapeake Llc |
Treatment of alzheimer's disease using compounds that reduce the activity of non-selective CA++ activated ATP-sensitive cation channels regulated by SUR1 channels
|
|
US7906555B2
(en)
|
2006-10-26 |
2011-03-15 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance
|
|
WO2008067196A2
(en)
|
2006-11-16 |
2008-06-05 |
The Regents Of The University Of California |
Methods for identifying inhibitors of solute transporters
|
|
US20080214486A1
(en)
|
2006-11-28 |
2008-09-04 |
Alcon Manufacturing, Ltd. |
RNAi-MEDIATED INHIBITION OF AQUAPORIN 4 FOR TREATMENT OF IOP-RELATED CONDITIONS
|
|
US20080171719A1
(en)
|
2006-11-28 |
2008-07-17 |
Alcon Manufacturing, Ltd. |
RNAi-MEDIATED INHIBITION OF AQUAPORIN 1 FOR TREATMENT OF IOP-RELATED CONDITIONS
|
|
WO2008089103A2
(en)
|
2007-01-12 |
2008-07-24 |
University Of Maryland, Baltimore |
Targeting ncca-atp channel for organ protection following ischemic episode
|
|
DK2118279T3
(en)
|
2007-01-16 |
2018-02-26 |
Ipintl Llc |
HIS UNKNOWN COMPOSITION FOR TREATMENT OF METABOLIC SYNDROME
|
|
US20120183600A1
(en)
|
2007-01-16 |
2012-07-19 |
Chien-Hung Chen |
Novel composition for treating metabolic syndrome and other conditions
|
|
WO2008098160A1
(en)
|
2007-02-09 |
2008-08-14 |
University Of Maryland, Baltimore |
Antagonists of a non-selective cation channel in neural cells
|
|
CN105123670B
(zh)
|
2007-02-17 |
2018-12-14 |
哈佛学院董事会 |
用于进行组织保存的组合物以及方法
|
|
TW200848063A
(en)
|
2007-04-23 |
2008-12-16 |
Combinatorx Inc |
Methods and compositions for the treatment of neurodegenerative disorders
|
|
CA3065983C
(en)
|
2007-06-22 |
2022-07-26 |
The United States Of America As Represented By The Department Of Veterans Affairs |
Inhibitors of ncca-atp channels for therapy
|
|
CN101842095B
(zh)
|
2007-07-02 |
2015-06-24 |
于明 |
肿瘤治疗的配方,方法和靶目标
|
|
US20090239868A1
(en)
|
2007-10-23 |
2009-09-24 |
Institute Of Medical Molecular Design, Inc. |
Inhibitor of pai-1 production
|
|
RU2010120675A
(ru)
*
|
2007-10-23 |
2011-11-27 |
Инститьют Оф Медисинал Молекьюлар Дизайн, Инк. (Jp) |
Ингибитор продуцирования pai-1
|
|
JP5812318B2
(ja)
|
2007-12-04 |
2015-11-11 |
レメディー ファーマシューティカルズ， インコーポレイテッド |
凍結乾燥のための改良された処方物および方法ならびにそれによって提供される凍結乾燥物
|
|
GB0724340D0
(en)
|
2007-12-13 |
2008-01-30 |
Univ Dundee |
Novel Therapeutic Agents
|
|
US8642660B2
(en)
|
2007-12-21 |
2014-02-04 |
The University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
|
WO2009097443A2
(en)
|
2008-01-29 |
2009-08-06 |
Remedy Pharmaceuticals, Inc. |
Liquid formulations of compounds active at sulfonylurea receptors
|
|
US8211882B2
(en)
|
2008-03-08 |
2012-07-03 |
Richard Delarey Wood |
Glutamate receptor modulators and therapeutic agents
|
|
US20090286799A1
(en)
|
2008-05-16 |
2009-11-19 |
Zhi-Gang Jiang |
Methods for the treatment of brain edema
|
|
US20110263478A1
(en)
|
2008-09-16 |
2011-10-27 |
Simard J Marc |
Sur1 inhibitors for therapy
|
|
US20120010178A1
(en)
|
2008-10-21 |
2012-01-12 |
President And Fellows Of Harvard College |
Methods and compounds for treatment of neurodegenerative disorders
|
|
GB0823366D0
(en)
|
2008-12-22 |
2009-01-28 |
Uni I Oslo |
Synthesis
|
|
JP5778583B2
(ja)
|
2009-01-12 |
2015-09-16 |
バギ リサーチ リミテッド |
炎症を治療するためおよび免疫応答を調節するための化合物ならびにそれらの使用
|
|
US20120039805A1
(en)
|
2009-02-20 |
2012-02-16 |
Pangea Biosciences, Inc. |
Therapeutics And Methods For Treating Neoplastic Diseases Comprising Determining The Level Of Caveolin-1 And/Or Caveolin-2 In A Stromal Cell Sample
|
|
US20130053318A1
(en)
|
2010-03-10 |
2013-02-28 |
Parry Laura |
Modulating aquaporins with relaxin
|
|
KR20180123176A
(ko)
|
2010-07-19 |
2018-11-14 |
바이오젠 체사피크 엘엘씨 |
글리부리드 및 다른 약물의 정맥내 투여를 위한 방법
|
|
WO2012013567A1
(en)
*
|
2010-07-28 |
2012-02-02 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition for treatment of respiratory and inflammatory diseases
|
|
US20110052678A1
(en)
|
2010-11-05 |
2011-03-03 |
Shantha Totada R |
Method for treating age related macular degeneration
|
|
WO2012125749A2
(en)
|
2011-03-14 |
2012-09-20 |
Io Therapeutics, Inc. |
INFLAMMATION AND AUTOIMMUNE DISORDER TREATMENT USING RARα SELECTIVE AGONISTS
|
|
DK2717883T3
(en)
|
2011-05-02 |
2017-04-24 |
Stichting Vumc |
PROTECTION AGAINST ENDOTELIAL BARRIER DYSFUNCTION BY INHIBITION OF THE TYROSINKINASE ABL RELATED GENES (ARG)
|
|
RU2461375C1
(ru)
*
|
2011-05-19 |
2012-09-20 |
Учреждение Российской академии медицинских наук Научно-исследовательский институт онкологии Сибирского отделения Российской академии медицинских наук (НИИ онкологии СО РАМН) |
Способ комбинированного лечения больных местно-распространенным раком желудка
|
|
WO2013152313A1
(en)
*
|
2012-04-05 |
2013-10-10 |
The Regents Of The University Of California |
Compositions and methods for treating cancer and diseases and conditions responsive to growth factor inhibition
|
|
ES2929283T3
(es)
|
2012-05-04 |
2022-11-28 |
Us Health |
Moduladores del receptor de relaxina 1
|
|
CN104602682B
(zh)
*
|
2012-05-08 |
2018-12-14 |
埃罗米克斯公司 |
用于治疗水通道蛋白介导的疾病的化合物
|
|
CN105636583B
(zh)
|
2013-09-13 |
2019-08-20 |
板井昭子 |
水溶液制剂及其制造方法
|
|
AU2014346682B2
(en)
|
2013-11-06 |
2020-03-12 |
Aeromics, Inc. |
Novel formulations
|
|
CA2931550C
(en)
|
2013-12-13 |
2023-09-26 |
Vertex Pharmaceuticals Incorporated |
Prodrugs of pyridone amides useful as modulators of sodium channels
|
|
WO2016077787A1
(en)
|
2014-11-13 |
2016-05-19 |
Aeromics, Llc |
Novel methods
|
|
AU2016271576B2
(en)
|
2015-05-29 |
2021-10-07 |
Biogen Chesapeake, Llc |
Methods of reducing or preventing intimal damage caused by mechanical stimulation of endothelial cells
|
|
JP7349786B2
(ja)
|
2015-10-07 |
2023-09-25 |
バイオジェン チェサピーク エルエルシー |
Ｃｎｓ浮腫に関連する損傷または状態を処置する方法
|
|
CA3022684A1
(en)
|
2016-05-13 |
2017-11-16 |
Aeromics, Inc. |
Crystals
|
|
EP4483955A3
(en)
|
2016-07-29 |
2025-03-12 |
Remedy Pharmaceuticals, Inc. |
Methods of medical treatment with sur1-trpm4 channel inhibitors
|
|
IL300341A
(en)
*
|
2020-08-05 |
2023-04-01 |
Jiangsu Simcere Pharm Co Ltd |
A pharmaceutical composition of an aquaporin inhibitor and a method for its preparation
|